APO Research
Talk to an analyst

APO RESEARCH · REPORT

Systemic Antifungals

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Systemic Antifungals Market Outlook and Growth Opportunities 2026

30 December 2025203 pages

Choose your research edition.

Industry ResearchSystemic Antifungals Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Systemic Antifungals Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Systemic Antifungals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Systemic Antifungals Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Systemic Antifungals Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Systemic Antifungals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Systemic Antifungals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Systemic Antifungals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Systemic Antifungals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Systemic Antifungals market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Systemic Antifungals market include MSD, Zhuhai Ebang Pharmaceutical, Chiatai Tianqing, Xian-janssen, Novartis, Merck, Livzon Group Livzon Pharmaceutical Factory, Honz Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Systemic Antifungals market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Systemic Antifungals and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Systemic Antifungals revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Systemic Antifungals market.

Systemic Antifungals Segment by Company

MSD

Zhuhai Ebang Pharmaceutical

Chiatai Tianqing

Xian-janssen

Novartis

Merck

Livzon Group Livzon Pharmaceutical Factory

Honz Pharmaceutical

Pfizer

CR Pharma

Haisco Pharmaceutical

Medisan

Chengdu Brilliant Pharmaceutical

Bayer

Liposome Company

Gilead Sciences

Astellas Pharma

Systemic Antifungals Segment by Type

Injections

Oral

Systemic Antifungals Segment by Application

Clinic

Hospital

Drugstores

Others

Systemic Antifungals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Systemic Antifungals status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Systemic Antifungals key companies, revenue, market share, and recent developments.

3. To split the Systemic Antifungals breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Systemic Antifungals market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Systemic Antifungals significant trends, drivers, influence factors in global and regions.

6. To analyze Systemic Antifungals competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Systemic Antifungals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Systemic Antifungals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Systemic Antifungals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Systemic Antifungals industry.

Chapter 3: Detailed analysis of Systemic Antifungals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Systemic Antifungals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Systemic Antifungals in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Systemic Antifungals Industry Trends Table 2. Systemic Antifungals Industry Drivers Table 3. Systemic Antifungals Industry Opportunities and Challenges Table 4. Systemic Antifungals Industry Restraints Table 5. Global Systemic Antifungals Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Systemic Antifungals Revenue Share by Company (2021-2026) Table 7. Global Systemic Antifungals Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Systemic Antifungals Key Company Manufacturing Base & Headquarters Table 9. Global Systemic Antifungals Company, Product Type & Application Table 10. Global Systemic Antifungals Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Systemic Antifungals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Injections Table 15. Significant Companies of Oral Table 16. Global Systemic Antifungals Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Systemic Antifungals Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Systemic Antifungals Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Systemic Antifungals Sales Value Share by Type (2021-2026) Table 20. Global Systemic Antifungals Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Clinic Table 22. Significant Companies of Hospital Table 23. Significant Companies of Drugstores Table 24. Significant Companies of Others Table 25. Global Systemic Antifungals Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Systemic Antifungals Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Systemic Antifungals Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Systemic Antifungals Sales Value Share by Application (2021-2026) Table 29. Global Systemic Antifungals Sales Value Share by Application (2027-2032) Table 30. Global Systemic Antifungals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Systemic Antifungals Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Systemic Antifungals Sales Value Share by Region (2021-2026) Table 33. Global Systemic Antifungals Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Systemic Antifungals Sales Value Share by Region (2027-2032) Table 35. Global Systemic Antifungals Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Systemic Antifungals Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Systemic Antifungals Sales Value Market Share by Country (2021-2026) Table 38. Global Systemic Antifungals Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Systemic Antifungals Sales Value Market Share by Country (2027-2032) Table 40. MSD Company Information Table 41. MSD Business Overview Table 42. MSD Systemic Antifungals Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. MSD Systemic Antifungals Product Portfolio Table 44. MSD Recent Development Table 45. Zhuhai Ebang Pharmaceutical Company Information Table 46. Zhuhai Ebang Pharmaceutical Business Overview Table 47. Zhuhai Ebang Pharmaceutical Systemic Antifungals Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Zhuhai Ebang Pharmaceutical Systemic Antifungals Product Portfolio Table 49. Zhuhai Ebang Pharmaceutical Recent Development Table 50. Chiatai Tianqing Company Information Table 51. Chiatai Tianqing Business Overview Table 52. Chiatai Tianqing Systemic Antifungals Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Chiatai Tianqing Systemic Antifungals Product Portfolio Table 54. Chiatai Tianqing Recent Development Table 55. Xian-janssen Company Information Table 56. Xian-janssen Business Overview Table 57. Xian-janssen Systemic Antifungals Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Xian-janssen Systemic Antifungals Product Portfolio Table 59. Xian-janssen Recent Development Table 60. Novartis Company Information Table 61. Novartis Business Overview Table 62. Novartis Systemic Antifungals Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Novartis Systemic Antifungals Product Portfolio Table 64. Novartis Recent Development Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Systemic Antifungals Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Merck Systemic Antifungals Product Portfolio Table 69. Merck Recent Development Table 70. Livzon Group Livzon Pharmaceutical Factory Company Information Table 71. Livzon Group Livzon Pharmaceutical Factory Business Overview Table 72. Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product Portfolio Table 74. Livzon Group Livzon Pharmaceutical Factory Recent Development Table 75. Honz Pharmaceutical Company Information Table 76. Honz Pharmaceutical Business Overview Table 77. Honz Pharmaceutical Systemic Antifungals Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Honz Pharmaceutical Systemic Antifungals Product Portfolio Table 79. Honz Pharmaceutical Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Systemic Antifungals Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Pfizer Systemic Antifungals Product Portfolio Table 84. Pfizer Recent Development Table 85. CR Pharma Company Information Table 86. CR Pharma Business Overview Table 87. CR Pharma Systemic Antifungals Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. CR Pharma Systemic Antifungals Product Portfolio Table 89. CR Pharma Recent Development Table 90. Haisco Pharmaceutical Company Information Table 91. Haisco Pharmaceutical Business Overview Table 92. Haisco Pharmaceutical Systemic Antifungals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Haisco Pharmaceutical Systemic Antifungals Product Portfolio Table 94. Haisco Pharmaceutical Recent Development Table 95. Medisan Company Information Table 96. Medisan Business Overview Table 97. Medisan Systemic Antifungals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Medisan Systemic Antifungals Product Portfolio Table 99. Medisan Recent Development Table 100. Chengdu Brilliant Pharmaceutical Company Information Table 101. Chengdu Brilliant Pharmaceutical Business Overview Table 102. Chengdu Brilliant Pharmaceutical Systemic Antifungals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Chengdu Brilliant Pharmaceutical Systemic Antifungals Product Portfolio Table 104. Chengdu Brilliant Pharmaceutical Recent Development Table 105. Bayer Company Information Table 106. Bayer Business Overview Table 107. Bayer Systemic Antifungals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Bayer Systemic Antifungals Product Portfolio Table 109. Bayer Recent Development Table 110. Liposome Company Company Information Table 111. Liposome Company Business Overview Table 112. Liposome Company Systemic Antifungals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Liposome Company Systemic Antifungals Product Portfolio Table 114. Liposome Company Recent Development Table 115. Gilead Sciences Company Information Table 116. Gilead Sciences Business Overview Table 117. Gilead Sciences Systemic Antifungals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Gilead Sciences Systemic Antifungals Product Portfolio Table 119. Gilead Sciences Recent Development Table 120. Astellas Pharma Company Information Table 121. Astellas Pharma Business Overview Table 122. Astellas Pharma Systemic Antifungals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Astellas Pharma Systemic Antifungals Product Portfolio Table 124. Astellas Pharma Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Systemic Antifungals Product Image Figure 2. Global Systemic Antifungals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Systemic Antifungals Market Size (2021-2032) & (US$ Million) Figure 4. Global Systemic Antifungals Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Injections Image Figure 8. Oral Image Figure 9. Global Systemic Antifungals Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Systemic Antifungals Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Systemic Antifungals Sales Value Share by Type (2021-2032) Figure 12. Clinic Image Figure 13. Hospital Image Figure 14. Drugstores Image Figure 15. Others Image Figure 16. Global Systemic Antifungals Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Systemic Antifungals Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Systemic Antifungals Sales Value Share by Application (2021-2032) Figure 19. Global Systemic Antifungals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Systemic Antifungals Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Systemic Antifungals Sales Value (2021-2032) & (US$ Million) Figure 22. North America Systemic Antifungals Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Systemic Antifungals Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Systemic Antifungals Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Systemic Antifungals Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Systemic Antifungals Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Systemic Antifungals Sales Value (2021-2032) & (US$ Million) Figure 28. South America Systemic Antifungals Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Systemic Antifungals Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Systemic Antifungals Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Systemic Antifungals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Systemic Antifungals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Systemic Antifungals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Injections
  • Oral
Applications
  • Clinic
  • Hospital
  • Drugstores
  • Others
Companies covered
  • MSD
  • Zhuhai Ebang Pharmaceutical
  • Chiatai Tianqing
  • Xian-janssen
  • Novartis
  • Merck
  • Livzon Group Livzon Pharmaceutical Factory
  • Honz Pharmaceutical
  • Pfizer
  • CR Pharma
  • Haisco Pharmaceutical
  • Medisan
  • Chengdu Brilliant Pharmaceutical
  • Bayer
  • Liposome Company
  • Gilead Sciences
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Systemic Antifungals Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Systemic Antifungals Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Systemic Antifungals Market Dynamics
  1. 2.1 Systemic Antifungals Industry Trends
  2. 2.2 Systemic Antifungals Industry Drivers
  3. 2.3 Systemic Antifungals Industry Opportunities and Challenges
  4. 2.4 Systemic Antifungals Industry Restraints
3 Systemic Antifungals Market by Company
  1. 3.1 Global Systemic Antifungals Company Revenue Ranking in 2025
  2. 3.2 Global Systemic Antifungals Revenue by Company (2021-2026)
  3. 3.3 Global Systemic Antifungals Company Ranking (2024-2026)
  4. 3.4 Global Systemic Antifungals Company Manufacturing Base and Headquarters
  5. 3.5 Global Systemic Antifungals Company Product Type and Application
  6. 3.6 Global Systemic Antifungals Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Systemic Antifungals Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Systemic Antifungals Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Systemic Antifungals Market by Type
  1. 4.1 Systemic Antifungals Type Introduction
  2. 4.1.1 Injections
  3. 4.1.2 Oral
  4. 4.2 Global Systemic Antifungals Sales Value by Type
  5. 4.2.1 Global Systemic Antifungals Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Systemic Antifungals Sales Value by Type (2021-2032)
  7. 4.2.3 Global Systemic Antifungals Sales Value Share by Type (2021-2032)
5 Systemic Antifungals Market by Application
  1. 5.1 Systemic Antifungals Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Drugstores
  5. 5.1.4 Others
  6. 5.2 Global Systemic Antifungals Sales Value by Application
  7. 5.2.1 Global Systemic Antifungals Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Systemic Antifungals Sales Value by Application (2021-2032)
  9. 5.2.3 Global Systemic Antifungals Sales Value Share by Application (2021-2032)
6 Systemic Antifungals Regional Value Analysis
  1. 6.1 Global Systemic Antifungals Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Systemic Antifungals Sales Value by Region (2021-2032)
  3. 6.2.1 Global Systemic Antifungals Sales Value by Region: 2021-2026
  4. 6.2.2 Global Systemic Antifungals Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Systemic Antifungals Sales Value (2021-2032)
  7. 6.3.2 North America Systemic Antifungals Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Systemic Antifungals Sales Value (2021-2032)
  10. 6.4.2 Europe Systemic Antifungals Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Systemic Antifungals Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Systemic Antifungals Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Systemic Antifungals Sales Value (2021-2032)
  16. 6.6.2 South America Systemic Antifungals Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Systemic Antifungals Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Systemic Antifungals Sales Value Share by Country, 2025 VS 2032
7 Systemic Antifungals Country-level Value Analysis
  1. 7.1 Global Systemic Antifungals Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Systemic Antifungals Sales Value by Country (2021-2032)
  3. 7.2.1 Global Systemic Antifungals Sales Value by Country (2021-2026)
  4. 7.2.2 Global Systemic Antifungals Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Systemic Antifungals Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Systemic Antifungals Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Systemic Antifungals Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Systemic Antifungals Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Systemic Antifungals Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Systemic Antifungals Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Systemic Antifungals Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Systemic Antifungals Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Systemic Antifungals Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Systemic Antifungals Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Systemic Antifungals Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Systemic Antifungals Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Systemic Antifungals Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Systemic Antifungals Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Systemic Antifungals Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Systemic Antifungals Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Systemic Antifungals Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Systemic Antifungals Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Systemic Antifungals Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Systemic Antifungals Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Systemic Antifungals Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Systemic Antifungals Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Systemic Antifungals Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Systemic Antifungals Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Systemic Antifungals Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Systemic Antifungals Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Systemic Antifungals Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Systemic Antifungals Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Systemic Antifungals Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Systemic Antifungals Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 MSD
  2. 8.1.1 MSD Company Information
  3. 8.1.2 MSD Business Overview
  4. 8.1.3 MSD Systemic Antifungals Revenue and Gross Margin (2021-2026)
  5. 8.1.4 MSD Systemic Antifungals Product Portfolio
  6. 8.1.5 MSD Recent Developments
  7. 8.2 Zhuhai Ebang Pharmaceutical
  8. 8.2.1 Zhuhai Ebang Pharmaceutical Company Information
  9. 8.2.2 Zhuhai Ebang Pharmaceutical Business Overview
  10. 8.2.3 Zhuhai Ebang Pharmaceutical Systemic Antifungals Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhuhai Ebang Pharmaceutical Systemic Antifungals Product Portfolio
  12. 8.2.5 Zhuhai Ebang Pharmaceutical Recent Developments
  13. 8.3 Chiatai Tianqing
  14. 8.3.1 Chiatai Tianqing Company Information
  15. 8.3.2 Chiatai Tianqing Business Overview
  16. 8.3.3 Chiatai Tianqing Systemic Antifungals Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chiatai Tianqing Systemic Antifungals Product Portfolio
  18. 8.3.5 Chiatai Tianqing Recent Developments
  19. 8.4 Xian-janssen
  20. 8.4.1 Xian-janssen Company Information
  21. 8.4.2 Xian-janssen Business Overview
  22. 8.4.3 Xian-janssen Systemic Antifungals Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Xian-janssen Systemic Antifungals Product Portfolio
  24. 8.4.5 Xian-janssen Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Systemic Antifungals Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Systemic Antifungals Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Systemic Antifungals Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Systemic Antifungals Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Livzon Group Livzon Pharmaceutical Factory
  38. 8.7.1 Livzon Group Livzon Pharmaceutical Factory Company Information
  39. 8.7.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
  40. 8.7.3 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product Portfolio
  42. 8.7.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
  43. 8.8 Honz Pharmaceutical
  44. 8.8.1 Honz Pharmaceutical Company Information
  45. 8.8.2 Honz Pharmaceutical Business Overview
  46. 8.8.3 Honz Pharmaceutical Systemic Antifungals Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Honz Pharmaceutical Systemic Antifungals Product Portfolio
  48. 8.8.5 Honz Pharmaceutical Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Systemic Antifungals Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Systemic Antifungals Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 CR Pharma
  56. 8.10.1 CR Pharma Company Information
  57. 8.10.2 CR Pharma Business Overview
  58. 8.10.3 CR Pharma Systemic Antifungals Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CR Pharma Systemic Antifungals Product Portfolio
  60. 8.10.5 CR Pharma Recent Developments
  61. 8.11 Haisco Pharmaceutical
  62. 8.11.1 Haisco Pharmaceutical Company Information
  63. 8.11.2 Haisco Pharmaceutical Business Overview
  64. 8.11.3 Haisco Pharmaceutical Systemic Antifungals Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Haisco Pharmaceutical Systemic Antifungals Product Portfolio
  66. 8.11.5 Haisco Pharmaceutical Recent Developments
  67. 8.12 Medisan
  68. 8.12.1 Medisan Company Information
  69. 8.12.2 Medisan Business Overview
  70. 8.12.3 Medisan Systemic Antifungals Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Medisan Systemic Antifungals Product Portfolio
  72. 8.12.5 Medisan Recent Developments
  73. 8.13 Chengdu Brilliant Pharmaceutical
  74. 8.13.1 Chengdu Brilliant Pharmaceutical Company Information
  75. 8.13.2 Chengdu Brilliant Pharmaceutical Business Overview
  76. 8.13.3 Chengdu Brilliant Pharmaceutical Systemic Antifungals Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Chengdu Brilliant Pharmaceutical Systemic Antifungals Product Portfolio
  78. 8.13.5 Chengdu Brilliant Pharmaceutical Recent Developments
  79. 8.14 Bayer
  80. 8.14.1 Bayer Company Information
  81. 8.14.2 Bayer Business Overview
  82. 8.14.3 Bayer Systemic Antifungals Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bayer Systemic Antifungals Product Portfolio
  84. 8.14.5 Bayer Recent Developments
  85. 8.15 Liposome Company
  86. 8.15.1 Liposome Company Company Information
  87. 8.15.2 Liposome Company Business Overview
  88. 8.15.3 Liposome Company Systemic Antifungals Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Liposome Company Systemic Antifungals Product Portfolio
  90. 8.15.5 Liposome Company Recent Developments
  91. 8.16 Gilead Sciences
  92. 8.16.1 Gilead Sciences Company Information
  93. 8.16.2 Gilead Sciences Business Overview
  94. 8.16.3 Gilead Sciences Systemic Antifungals Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Gilead Sciences Systemic Antifungals Product Portfolio
  96. 8.16.5 Gilead Sciences Recent Developments
  97. 8.17 Astellas Pharma
  98. 8.17.1 Astellas Pharma Company Information
  99. 8.17.2 Astellas Pharma Business Overview
  100. 8.17.3 Astellas Pharma Systemic Antifungals Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Astellas Pharma Systemic Antifungals Product Portfolio
  102. 8.17.5 Astellas Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst